辛伐他汀对血小板氧化低密度脂蛋白内皮受体-1及CD40L表达影响的体外研究
被引量:2
摘要
血小板直接参与急性冠状动脉(冠脉)综合征患者心血管事件的发生和发展。临床上使用的抗血小板药物通过不同的途径协同作用,起到防治血栓、抑制炎症、稳定斑块的作用。近来发现他汀类药物具有许多调脂作用外的多效性作用,可使心血管事件危险减少,其对血小板的作用也受到越来越多的关注。
出处
《中国药物与临床》
CAS
2010年第3期336-337,共2页
Chinese Remedies & Clinics
参考文献10
-
1Puddu P,Muscari A,Puddu GM,et al. The complexity of platelet metabolism and its contribution to atherothrombosis. Acta Cardiol, 2009,64 (2):157-165.
-
2Chen M,Kakutani M,Naruko T,et al. Activation-dependent surface expression of LOX-1 in human platelets.Biochem Biophys Res Commun,2001,282 (1):153-158.
-
3Hayashida K,Kume N,Murase T,et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation, 2005,112 (6):778-780.
-
4Chen LY, Mehta P, Mehta JL. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation, 1996,93:1740-1746.
-
5Marwali MR,Hu CP,Mohandas B,et al. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1 ,nitric oxide,oxidative stress,and inside-out integrin signaling. J Pharmacol Exp Ther, 2007,322(3): 1324-1332.
-
6Puccetti L, Sawamura T, Pasqui AL, et al. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients. Eur J Clin Invest,2005,35: 47-51.
-
7Lutgens E,Daemen MJ. CD40-cCD40L interactions in atherosclerosis. Trends Cardiovasc Med,2002,12:27-32.
-
8Schonbeck U,Sukhova GK,Schonbeck U,et al. Inhibition of CD40 signaling limits evolution established atherosclerosis in mice. Proe Natl Acad Sci USA,2000,97:7458-7463.
-
9Peng DQ,Zhao SP,Li YF,et al. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta,2002,319(1):19-26.
-
10Jin Y,Nonoyama S,Morio T,et al. Characterization of soluble CD40 ligand released from human activated platelets. J Med Dent Sci, 2001,48 (1):23-27.
同被引文献22
-
1蒋连保,谢荣秋.阿司匹林+辛伐他汀对急性冠脉综合征中高敏性C-反应蛋白的影响及其意义[J].中国实用医药,2007,2(2):67-69. 被引量:5
-
2刘永胜,沈青山,朱锐,付度关,汤永谦,陶红,李素珍,叶剑文.氟伐他汀对不稳定型心绞痛患者CRP、TNF-α和cTnI的影响[J].国外医学(心血管疾病分册),2005,32(5):307-308. 被引量:8
-
3Malarstig A,Lindahl B,Wallentin L,et al.Soluble CIM OL levels are regulated by the 3459A 》G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome[J].Arterioscler Thromb Vasc Bio1,2006,26(1):1667-1673.
-
4Libby P,Ridker PM,Maseri A.Inflammation and athleroselerosis[J].Circulation,2005,105(3):1135-1137.
-
5高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2006:1-3.
-
6Cholene JM,Blumberg N,Phipps RP,et al.Developmental changes in soluble CD40 ligand[J].J Pediatr,2008,152(1):50-54.
-
7Johnson JL.Matrix metalloproteinases:influence on smooth muscle cells and atherfselerotie plaque stability[J].Expert Rev Cardiovase Ther,2007,5(2):265-282.
-
8Davies MJ.Reactive oxygen species,metalloproteinases,and plaque stability[J].Circulation,1998,97(24):2382-2383.
-
9Puddu P,Muscari A,Puddu GM,et al.The complexity of platelet metabolism and its contribution to atherothrombosis[J].Acta Cardiol,2009,64(2):157-165.
-
10中华人民共和国卫生部.中药新药临床研究指导原则[s].北京:人民卫生出版社,1993.28~30.
二级引证文献19
-
1牛津津,胡钢.CD40/CD154与动脉粥样硬化及他汀类药物干预的研究进展[J].长江大学学报(自科版)(下旬),2012,8(11):64-66. 被引量:2
-
2杨雪娥,刘焱.氯吡格雷联合阿司匹林治疗不稳定型心绞痛42例疗效观察[J].现代诊断与治疗,2012,23(8):1168-1169.
-
3张兰芳,陈春红,尹博英,王占启,陈彦霞.瑞舒伐他汀对急性心肌梗死患者心室重构及心功能的影响[J].临床合理用药杂志,2013,6(23):3-4. 被引量:2
-
4姚欣,沈先敏.阿托伐他汀治疗不稳定型心绞痛的Meta分析[J].现代中西医结合杂志,2013,22(25):2757-2758. 被引量:5
-
5翟小亚,郭航远,池菊芳,季政,唐伟良,赵飞,蒋承建.黄酒多酚对LDLR^(-/-)小鼠MMP-2、MMP-9、TIMP-1、TIMP-2表达和动脉粥样硬化斑块的影响[J].中国动脉硬化杂志,2013,21(12):1069-1074. 被引量:14
-
6张子文.辛伐他汀对不稳定性心绞痛患者血液hs-CPR、UA、LDL-C水平及预后的影响[J].山东医药,2014,54(1):53-54. 被引量:3
-
7马雪梅.银杏达莫注射液联合阿托伐他汀钙治疗老年不稳定型心绞痛的疗效观察[J].中医临床研究,2014,6(25):50-51. 被引量:3
-
8陈永清.不同剂量辛伐他汀对老年高血压合并高脂血症的疗效[J].北方药学,2015,12(4):46-47. 被引量:4
-
9王超.舒血宁注射液联合阿托伐他汀治疗不稳定型心绞痛临床疗效及对血清hs-CRP的影响研究[J].海峡药学,2015,27(3):129-130. 被引量:2
-
10王泽荣.银杏达莫联合阿托伐他汀钙对老年不稳定型心绞痛患者血脂水平的影响[J].实用心脑肺血管病杂志,2015,23(4):61-63. 被引量:7
-
1楚罗湘,赖沙毅,谢剑,吴昊.早期辛伐他汀强化治疗对急性冠状动脉综合征患者血小板氧化低密度脂蛋白内皮受体-1表达的影响[J].临床心血管病杂志,2010,26(2):121-123. 被引量:2
-
2严庆场,吴广华.瑞舒伐他汀对急性冠脉综合征患者CRP、LOX-1的影响[J].中华全科医学,2011,9(4):581-581. 被引量:13
-
3盛宏光,邱凌,郭郁郁,龚家雷.氧化低密度脂蛋白内皮受体-1在糖尿病大鼠肾皮质的基因表达[J].上海医学,2004,27(5):346-347.
-
4严金川,吴宗贵,陈金明,黄超,张玲珍,李莉,仲人前.细胞因子对人单核/巨噬细胞表达CD40和CD40L的影响[J].第二军医大学学报,2001,22(2):127-129. 被引量:9
-
5孙定军,陈漠水,邢波,陆士娟,林德洪,杜子军,李大严.急性冠脉综合征PCI术后血清sCD40L,MPO水平的变化以及阿托伐他汀对二者的影响[J].海南医学院学报,2013,19(10):1401-1405. 被引量:4
-
6邱凌,盛宏光,郭郁郁,龚家雷.血栓调节蛋白、细胞内黏附分子-1及氧化低密度脂蛋白内皮受体-1在糖尿病大鼠肾皮质的基因表达[J].上海医学,2006,29(5):309-311. 被引量:1
-
7黄鹤飞,项美香.他汀类药物在心房颤动治疗中的多效性作用[J].浙江医学,2012,34(15):1313-1315.
-
8张雅媛,鲍华英,张兰芳,施圣云,叶宁,钱小青,胡正.川崎病患儿CD4^+T淋巴细胞表面CD_(40)L表达及其与冠状动脉损伤的关系[J].实用儿科临床杂志,2005,20(11):1071-1073. 被引量:2
-
9王世俊,刘东海.SLE患者外周血淋巴细胞的CD_(40)-CD_(40)L表达及意义[J].浙江临床医学,2008,10(4):561-561.
-
10严金川,吴宗贵,陈金明,张玲珍,李莉,仲人前.氧化低密度脂蛋白及抗氧化剂对人脐静脉内皮细胞表达CD_(40)和CD_(40)L的影响[J].中国微循环,2002,6(1):15-17. 被引量:3